368 related articles for article (PubMed ID: 28854909)
1. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
2. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
Gaul C; Diener HC; Danesch U;
J Headache Pain; 2015; 16():516. PubMed ID: 25916335
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of nutraceuticals in migraine prophylaxis.
D'Onofrio F; Raimo S; Spitaleri D; Casucci G; Bussone G
Neurol Sci; 2017 May; 38(Suppl 1):117-120. PubMed ID: 28527067
[TBL] [Abstract][Full Text] [Related]
4. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
Shrivastava R; Pechadre JC; John GW
Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
6. Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis.
Vikelis M; Dermitzakis EV; Vlachos GS; Soldatos P; Spingos KC; Litsardopoulos P; Kararizou E; Argyriou AA
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375459
[TBL] [Abstract][Full Text] [Related]
7. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
8. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Maizels M; Blumenfeld A; Burchette R
Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
[TBL] [Abstract][Full Text] [Related]
9. The use of nutraceutics in children's and adolescent's headache.
Sangermani R; Boncimino A
Neurol Sci; 2017 May; 38(Suppl 1):121-124. PubMed ID: 28527085
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial.
Shoeibi A; Olfati N; Soltani Sabi M; Salehi M; Mali S; Akbari Oryani M
Acta Neurol Belg; 2017 Mar; 117(1):103-109. PubMed ID: 27670440
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.
Parohan M; Sarraf P; Javanbakht MH; Foroushani AR; Ranji-Burachaloo S; Djalali M
Nutr Neurosci; 2021 Apr; 24(4):317-326. PubMed ID: 31241007
[No Abstract] [Full Text] [Related]
14. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials.
Parohan M; Sarraf P; Javanbakht MH; Ranji-Burachaloo S; Djalali M
Nutr Neurosci; 2020 Nov; 23(11):868-875. PubMed ID: 30727862
[No Abstract] [Full Text] [Related]
15. Open label trial of coenzyme Q10 as a migraine preventive.
Rozen TD; Oshinsky ML; Gebeline CA; Bradley KC; Young WB; Shechter AL; Silberstein SD
Cephalalgia; 2002 Mar; 22(2):137-41. PubMed ID: 11972582
[TBL] [Abstract][Full Text] [Related]
16. Feverfew for migraine prophylaxis.
Henneicke-von Zepelin HH
Headache; 2006 Mar; 46(3):531. PubMed ID: 16618282
[No Abstract] [Full Text] [Related]
17. The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial.
Hajihashemi P; Askari G; Khorvash F; Reza Maracy M; Nourian M
Cephalalgia; 2019 Apr; 39(5):648-654. PubMed ID: 30612463
[TBL] [Abstract][Full Text] [Related]
18. Nutraceuticals and migraine: further strategy for the treatment of specific conditions.
Quintana S; Russo M; Torelli P
Neurol Sci; 2022 Nov; 43(11):6565-6567. PubMed ID: 35792970
[TBL] [Abstract][Full Text] [Related]
19. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
Murphy JJ; Heptinstall S; Mitchell JR
Lancet; 1988 Jul; 2(8604):189-92. PubMed ID: 2899663
[TBL] [Abstract][Full Text] [Related]
20. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
